Today's Biggest Moving Stocks

Ahead of its 10-for-1 stock split on June 7, trading volume on Nvidia (NVDA) continues to top the list. Investors should expect the lower stock price to attract more retail investors. NVDA stock closed at $1,164.37 on Tuesday. Existing shareholders do not need to do anything. They will hold ten times more shares worth around $116, assuming the most recent price close.

In the drug manufacturing sector, Pfizer (PFE) may potentially break out back to $30.00. The stock bottomed at $25.20 in late April 2024. On June 4, the firm reported breast cancer therapy drug PF-07248144 “led to a tolerable safety profile and durable antitumor activity.”

On May 31, 2024, Pfizer posted long-term data for its lung cancer therapy, Lorbrena (lorlatinib). The drug cut the risk of disease progression or death by 81%.

AstraZeneca (AZN) will likely find new highs in the coming weeks. Its CEO, Pascal Soriot, is confident that it may almost double its revenue by the end of this decade (2030). It is targeting revenue of $80 billion, compared to $45.8 billion in 2023. It will release 20 new drugs by 2030.

For the second time this year, GameStop (GME) lost its price rise momentum. Broker-dealers like Apex Fintech Solutions are questioning Morgan Stanley’s (MS) position of banning trader “Roaring Kitty.” His screen share of the GME position fueled the stock rally.

Source link

About The Author

Scroll to Top